Peregrine Capital Management’s Akero Therapeutics AKRO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-95,447	Closed	-$4.83M	–	319
2023 Q3	$4.83M	Buy	+95,447	New	+$4.83M	0.14%	233